Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.78K Hold
3
– – ﹤0.01% 1451
2026
Q1
$2.19K Hold
3
– – ﹤0.01% 1503
2025
Q4
$2.52K Hold
3
– – ﹤0.01% 954
2025
Q3
$2.21K Hold
3
– – ﹤0.01% 990
2025
Q2
$1.65K Sell
3
-2
-40% -$1.16K ﹤0.01% 1017
2025
Q1
$2.96K Hold
5
– – ﹤0.01% 961
2024
Q4
$3.08K Hold
5
– – ﹤0.01% 938
2024
Q3
$2.71K Buy
5
+2
+67% +$1.01K ﹤0.01% 939
2024
Q2
$1.29K Buy
3
+1
+50% +$383 ﹤0.01% 1028
2024
Q1
$787 Sell
2
-3
-60% -$1.16K ﹤0.01% 1013
2023
Q4
$1.9K Buy
+5
New +$2.33K ﹤0.01% 916
2023
Q3
– Sell
-3
Closed -$1.17K – 277
2023
Q2
$1.17K Buy
+3
New +$1.18K ﹤0.01% 919

Other funds holding ARGX

CVA Family Office's ARGX Position: Q2 2026 in Review

CVA Family Office held its argenx (ARGX) position steady in Q2 2026 at 3 shares worth $2.78K. The position accounts for ﹤0.01% of the portfolio, ranked #1451.

CVA Family Office first reported a position in ARGX in Q2 2023 and has held it in 12 quarters since. The position peaked at $3.08K in Q4 2024. 508 funds tracked by Wall St. Rank hold ARGX as of Q2 2026.

  • CVA Family Office held 3 shares of argenx worth $2.78K as of Q2 2026.
  • CVA Family Office left its argenx share count unchanged in Q2 2026.
  • argenx made up ﹤0.01% of CVA Family Office's portfolio in Q2 2026, its #1451 holding.
  • CVA Family Office first reported a position in argenx in Q2 2023 and has held it in 12 quarters since.
  • CVA Family Office's argenx position peaked at $3.08K in Q4 2024.
  • 508 funds tracked by Wall St. Rank held argenx as of Q2 2026.

Based on CVA Family Office's 13F filing for Q2 2026, filed 7 Aug 2026.